Work

Omalizumab and Mast Cell Disorders: Are We There Yet?

Year: 2019

Type: editorial

Source: The Journal of Allergy and Clinical Immunology In Practice

DOI: 10.1016/j.jaip.2019.04.030

Author: Catherine R. Weiler

Institution: Mayo Clinic

Language: English

Topic: Mast cells and histamine

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2971582433

Cites: 15

Cited by: 8

Related to: 10